Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

Author： Mansi Janine   Yellowlees Ann   Lipscombe Julian   Earl Helena   Cameron David   Coleman Robert   Perren Timothy   Gallagher Christopher   Quigley Mary   Crown John   Jones Alison   Highley Martin   Leonard Robert   Jeffry Evans T.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.122, Iss.3, 2010-08, pp. : 787-794

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer

By Lyman Gary   Green Stephanie   Ravdin Peter   Geyer Charles   Russell Christy   Balcerzak Stanley   Thomas Budd G.   Martino Silvana  

Breast Cancer Research and Treatment, Vol. 85, Iss. 2, 2004-05 ,pp. : 143-150

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of Ifosfamide+Doxorubicin in patients with advanced synovial sarcomas (E1793): a trial of the Eastern Cooperative Oncology Group

By Edmonson John H.   Ryan Louise M.   Falkson Carla I.   Hicks David G.   Blum Ronald H.  

Sarcoma, Vol. 7, Iss. 1, 2003-01 ,pp. : 9-11

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin - a Gynecologic Oncology Group study

By Naumann R. Wendel  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 33-34

Informa Healthcare

Access to resources Recommend Favorite

Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer: 5-year Results from The Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan

By Morimoto T.   Ogawa M.   Orita K.   Sugimachi K.   Toge T.   Dohi K.   Nomura Y.   Monden Y.   Ogawa N.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 235-242

Elsevier

Access to resources Recommend Favorite

Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer-a randomised study with more than 10 years follow-up from the danish breast cancer cooperative gr

By Andersson M.   Lindegaard Madsen E.   Overgaard M.   Rose C.   Dombernowsky P.   Mouridsen H.T.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite